Results 131 to 140 of about 1,932,765 (302)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

OTHER TITLES: Education in Kansas: 2000-2001 Accountability Report. Kansas Quality Performance Accreditation Accountability Report For--. [Kansas State Board of Education Annual Report, 2000-2001]. Kansas State Department of Education Annual Report

open access: yes, 2001
Executive Summary -- National Tests -- Assessment Changes -- Reading Results -- Math Results -- Science Results -- Social Studies Results -- Standard of Excellence -- Advanced Math & Science -- What’s Working in the Schools -- Reading as a School-Wide ...
Kansas. State Board of Education
core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

OTHER TITLES: Accountability Report, 2009-2010. Education Summary, 2009-2010. [Kansas State Board of Education Annual Report, 2009-2010]. Kansas State Department of Education Annual Report

open access: yes, 2011
"January 2011.""The information in these pages provides an overview of Kansas student performance during the 2009-10 school year, both at the state level and nationally.
Kansas. State Board of Education
core  

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Entrepreneurship Education and Graduate Employment in Nasarawa State [PDF]

open access: yesOvidius University Annals: Economic Sciences Series
The study aimed to analyze the relationship between entrepreneurship education and graduate employment in Nasarawa State, addressing rising unemployment among graduates despite entrepreneurship education being part of their curriculum. A sample size of
Danjuma Nungala Usman   +2 more
doaj  

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

103rd Annual Report of the State Superintendent of Education of the State of South Carolina, 1971 [PDF]

open access: yes, 1971
The South Carolina State Superintendent of Education annually reported to the General Assembly the contention and progress of the public schools, including statistics such as the number of students, school districts, teacher salaries, and financial ...
South Carolina Budget and Control Board   +1 more
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy